Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped

Go back to Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 12.22 +0.02 (0.16%)
Previous Close $12.20    52 Week High $7.95 
Open $11.79    52 Week Low $0.40 
Day High $12.58    P/E N/A 
Day Low $11.78    EPS $-5.33 
Volume 230,664